“Real-World Longitudinal Impact of Elexacaftor–Tezacaftor–Ivacaftor Therapy on the Quality of Life of Children and Adolescents with Cystic Fibrosis in Northeastern: systemic inflammation in people with cystic fibrosis” dataset
Published: 6 March 2026| Version 1 | DOI: 10.17632/gktjfz822n.1
Contributor:
ISABEL SENADescription
This is the dataset used to make the research “Real-World Longitudinal Impact of Elexacaftor–Tezacaftor–Ivacaftor Therapy on the Quality of Life of Children and Adolescents with Cystic Fibrosis in Northeastern: systemic inflammation in people with cystic fibrosis".
Files
Categories
Cystic Fibrosis, Healthcare Quality